LATEST NEWS

Search Results for:

Homepage

Building new cancer therapies atom by atom. ABOUT US Nanobiotix is a late-stage clinical biotechnology company that is pioneering the discovery, development, manufacture, and commercialization of physics-based nanotherapeutics. We aim to create products that will transform outcomes for millions of people fighting cancer worldwide. About Us Our lead candidate NBTXR3 is a potential first-in-class radioenhancer […]

Homepage Read More »

ASTRO 2023

ASTRO 2023 65th Annual Meeting of American Society for Radiation Oncology 1st–4th October, 2023San Diego Convention Center, San Diego, CA, USA Nanobiotix will be presenting (oral presentation) the final readout on primary objectives from Study 102 Dose Expansion—the expansion part of a phase I dose escalation and dose expansion study evaluating potential first-in-class radioenhancer NBTXR3

ASTRO 2023 Read More »

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.